Stock Price
1.30
Daily Change
0.05 4.00%
Monthly
18.18%
Yearly
8.33%
Q2 Forecast
1.22

Actinium Pharmaceuticals reported $54.37M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Actinium Pharmaceuticals USD 54.37M 6.66M Sep/2025
Amgen USD 29.06B 1.17B Dec/2025
Bioline Rx USD 28.52M 3.34M Sep/2025
Capricor Therapeutics USD 322.94M 221.99M Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025